Redmile Group, LLC

Average Profitability
11.45%
Insider Buys Quantity
48
Insider Buys Sum
$563.63M
Insider Sells Quantity
9
Insider Sells Sum
$23.36M

Insider Activity of Redmile Group, LLC

According to the SEC Form 4 filings, Redmile Group, LLC, being in a position of

  1. 10 percent owner at ADC Therapeutics SA,
    оver the last 12 months, has bought 1000000 shares for $2.86M, and sold 25352 shares for $52,479,
    over all time since 2024-07-01, has bought 1000000 shares for $2.86M, and sold 25352 shares for $52,479.

The largest purchase of all time was on 2020-10-14 and amounted to 6882352 shares of Shattuck Labs, Inc. for $119.34M.

The largest sale of all time was on 2016-09-28 and amounted to 2492578 shares of Array Technologies, Inc. for $15.85M.

Biography of Redmile Group, LLC

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$3,692,293457
Sells
$793,136343

Comparison of Insiders on Amount of Buys and Sells

2024-12-20SaleFate Therapeutics, Inc.
FATE
341,633
0.2991%
$1.68$573,943-22.02%
2024-12-20PurchaseFate Therapeutics, Inc.
FATE
397,964
0.3484%
$1.68$668,580-22.02%
2024-12-11PurchaseADC Therapeutics SA
ADCT
10 percent owner
200,000
0.2806%
$3.04$609,000-20.95%
2024-12-04SaleADC Therapeutics SA
ADCT
10 percent owner
25,352
0.0263%
$2.07$52,479-14.98%
2024-12-04SaleShattuck Labs, Inc.
STTK
133,371
0.2728%
$1.25$166,714-3.2%
2024-12-04PurchaseShattuck Labs, Inc.
STTK
133,371
0.2728%
$1.25$166,714-3.2%
2024-07-01PurchaseADC Therapeutics SA
ADCT
10 percent owner
800,000
0.9607%
$2.81$2.25M-23.91%
2024-03-01PurchaseAbsci Corporation
ABSI
director
222,222
0.1982%
$4.50$999,999-24.91%
2023-12-26PurchaseFate Therapeutics, Inc.
FATE
44,630
0.0455%
$3.72$166,024+2.15%
2023-06-29SaleIGM Biosciences, Inc.
IGMS
director
80,423
0.1809%
$9.42$757,585-11.25%
2023-06-29PurchaseIGM Biosciences, Inc.
IGMS
director
80,423
0.1809%
$9.42$757,585-11.25%
2023-04-21PurchaseFate Therapeutics, Inc.
FATE
256,639
0.26%
$6.18$1.59M-27.01%
2023-04-20PurchaseFate Therapeutics, Inc.
FATE
20,000
0.0204%
$5.99$119,800-24.17%
2023-04-14SaleFate Therapeutics, Inc.
FATE
302,339
0.2996%
$5.84$1.77M-24.46%
2023-04-14PurchaseFate Therapeutics, Inc.
FATE
25,700
0.0262%
$6.00$154,200-24.46%
2022-10-13PurchaseZymeworks Inc.
ZYME
10 percent owner
30,481
0.0481%
$5.03$153,435+63.8%
2021-11-02PurchaseEntrada Therapeutics, Inc.
TRDA
10 percent owner
2M
25.0465%
$20.00$40M-53.61%
2021-07-26PurchaseAbsci Corporation
ABSI
director
1.88M
1.7426%
$16.00$30M-63.43%
2021-06-21PurchaseVerve Therapeutics, Inc.
VERV
10 percent owner
2.1M
13.5677%
$19.00$39.9M-7.41%
2021-01-08PurchaseFate Therapeutics, Inc.
FATE
327,485
0.2577%
$85.50$28M-33.06%
Total: 57
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.